Tempus AI, Inc. (TEM) Stock Profile & Financial OverviewTempus AI, Inc.
TEM Company Overview & Business Description
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Key Information
Current Trend for TEM
An assessment of the current trend environment for TEM, based on the latest closing price data and intended to describe the market context heading into the next trading session.
As of 2025-12-24, the current trend for TEM is a Bearish Regime (Sustained Downward Pressure).
Price is trending below the adaptive KAMA with a declining slope and elevated efficiency ratio, indicating a medium-term bearish environment.
- Price is currently trending at a healthy distance, sitting -1.96 ATR away from the adaptive KAMA baseline.
- The current market structure is holding within recent defined ranges.
Explore More Data
Adaptive Trend Model · Daily & Weekly (2025-12-24 ET)
This model uses an adaptive trend algorithm based on daily and weekly price data to identify whether a stock is in an uptrend, downtrend, or consolidation over a multi-week to multi-month horizon. Compared with traditional moving-average systems, it filters short-term noise more effectively, captures trend continuation more reliably, and provides a stronger basis for position sizing and risk-management decisions such as stop-loss and take-profit levels.
As of 2025-12-24, TEM showing momentum fatigue; Long-term trend is bullish.
Trend Strength: TEM last closed at 64.26, trading 0.4 ATR below the adaptive KAMA baseline (65.76). Technical Classification: Late-Cycle / Momentum Divergence.
Trend Score: Technical Score: 55/100. Classification: Late/Exhausted. Alignment: Indeterminate. Logic: Price action is range-bound or lacking sufficient slope for trend confirmation.
SuperTrend Risk: Risk indicators: No active structural constraints identified.
Risk Skew: Multi-timeframe risk skew is currently assessed as Conflicted / Pullback. The daily decline is occurring within a larger weekly uptrend. This suggests a corrective phase, where downside risk meets significant long-term structural support.
Key Levels: Key technical references: Spot 64.26, KAMA 65.76.